KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Gains from Investment Securities: 2009-2024

Historic Gains from Investment Securities for Dynavax Technologies (DVAX) over the last 16 years, with Dec 2024 value amounting to $925,000.

  • Dynavax Technologies' Gains from Investment Securities was N/A to $925,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $2.6 million, marking a year-over-year change of. This contributed to the annual value of $925,000 for FY2024, which is 90.86% down from last year.
  • Per Dynavax Technologies' latest filing, its Gains from Investment Securities stood at $925,000 for FY2024, which was down 90.86% from $10.1 million recorded in FY2023.
  • Dynavax Technologies' Gains from Investment Securities' 5-year high stood at $10.4 million during FY2021, with a 5-year trough of $925,000 in FY2024.
  • In the last 3 years, Dynavax Technologies' Gains from Investment Securities had a median value of $9.3 million in 2022 and averaged $6.8 million.
  • Per our database at Business Quant, Dynavax Technologies' Gains from Investment Securities rose by 22.27% in 2021 and then slumped by 90.86% in 2024.
  • Dynavax Technologies' Gains from Investment Securities (Yearly) stood at $8.5 million in 2020, then rose by 22.27% to $10.4 million in 2021, then fell by 10.19% to $9.3 million in 2022, then grew by 8.36% to $10.1 million in 2023, then crashed by 90.86% to $925,000 in 2024.